References
- Cuttler L, Van Vliet G, Conte F A, Kaplan S L, Grumbach M M. SomatomedinC levels in children and adolescents with gonadal dysgenesis: differences from age-matched normal females and effect of chronic estrogen replacement therapy. J Clin End Metabol 1985; 60: 1087–92
- Creatsas G, Arefetz N, Adamopoulos P N, Konstantellou E, Aravantinos D. Transdermal estradiol plus oral medroxyprogesterone acetate replacement therapy in primary amenorrheic adolescents. Clinical, hormonal and metabolic aspects. Matuntar 1994; 18: 10
- Gisternino M, Nahoul K, Borrola M, Grignani G, Perani G, Sampaolo P, Roger M, Severi F. Transdermal estradiol substitution therapy for the induction of puberty in female hypogonadism. J End Invest 1991; 14: 481
- Creatsas G, Malamitsi-Puchner A, Hassan E. Endothelin plasma levels in primary amenorrheic adolescents before and after estrogen treatment. J Soc Gynecol Invest, in press